SUBSCRIBE
SUBSCRIBE

Gilead Sciences, Inc.

NEWS
Business
Mixed Earnings Forecast for Big Pharma
January 23, 2008
 · 
1 min read
Business
Gilead Sciences, Inc. HIV Drugs Drive Profit After Year-Ago Loss
October 19, 2007
 · 
1 min read
Biotech Bay
Gilead Sciences, Inc.'s Touch
September 5, 2007
 · 
4 min read
Celgene (Jobs), Genentech, Inc. (Jobs), Gilead Sciences, Inc. (Jobs): Is Biotech Weakness Creating A Buying Opportunity?
July 5, 2007
 · 
1 min read
Business
Genentech, Inc.(Jobs), Gilead Sciences, Inc.(Jobs) Struggle to Find Scientists as Biotech Booms
March 30, 2007
 · 
1 min read
Biotech Beach
New AIDS Drugs Offer Hope for Long-Term Patients
March 2, 2007
 · 
1 min read
Biotech Beach
The Day In Review: Sanofi-Aventis (France) Loses Lovenox Patent
February 9, 2007
 · 
1 min read
BioMidwest
Americans Piled Up Tamiflu On Bird Flu Fear
October 17, 2006
 · 
1 min read
Biotech Bay
The Day In Review: Gilead Sciences (Foster City, CA) Gets Myogen In $2.5 Billion Deal
October 2, 2006
 · 
1 min read
Load More
  • 2025 BPTW Badge - RBG.png
  • 2024 Best Places to Work
  • 2023 Best Places to Work
  • 2022 Best Places to Work
JOBS
IN THE PRESS
Drug Development
Gilead Sciences, Inc.'s Hepatitis C Drug Works Better: FDA Reviewers
October 23, 2013
 · 
1 min read
Business
Gilead Sciences, Inc. to Release Third Quarter 2013 Financial Results on Tuesday, October 29, 2013
October 23, 2013
 · 
1 min read
Drug Development
Gilead Sciences, Inc.'s Single Tablet HIV Regimen Stribild® Demonstrates Durable Viral Suppression Through Three Years of Therapy
October 16, 2013
 · 
1 min read
Drug Development
Gilead Sciences, Inc.'s Idelalisib Works Against Leukemia, Phase 3 Trial Stopped Early; Stock Up +6.42% at Market Close (October 10, 2013)
October 10, 2013
 · 
5 min read
FDA
European Commission (EC) Approves Gilead Sciences, Inc.’ Tybost™, a New Boosting Agent for HIV Therapy
September 26, 2013
 · 
9 min read
Drug Development
Gilead Sciences, Inc.'s Tenofovir Alafenamide (TAF)-Based Single Tablet HIV Regimen Maintains High Viral Suppression Through 48 Weeks in Phase 2 Study
September 13, 2013
 · 
1 min read
Policy
Gilead Sciences, Inc. Takes Its First Swing at Cancer, Submits New Drug Application for Lymphoma Drug
September 12, 2013
 · 
5 min read
Drug Development
National Institutes of Health (NIH): Gilead Sciences, Inc. Drug Combined With Ribavirin Cures Hard-to-Treat Hep C Patients
August 28, 2013
 · 
1 min read
Policy
FDA Ordered to Cough Up Docs Regarding Gilead Sciences, Inc. Drug
August 8, 2013
 · 
4 min read
China’s SIPO Voids Patent for Gilead Sciences, Inc.'s Viread
July 30, 2013
 · 
1 min read
Load More